In this review, we will highlight the role of late gadolinium enhancement, along with other strengths available by cardiac MRI, in determining the underlying etiology of various nonischemic cardiomyopathies. Furthermore, we will also emphasize how late gadolinium enhancement may serve as a novel risk stratification tool to further impact patient care.
Keywords: CMR; dilated cardiomyopathy; late gadolinium enhancement; left ventricular noncompaction; nonischemic cardiomyopathy.